Factors affecting the efficacy of peripheral blood progenitor cells collections by large-volume leukaphereses with standardized processing volumes
Corresponding Author
Uwe Cassens
From the Institute of Transfusion Medicine, the Department of Medical Informatics and Biomathematics, the Department of Medicine/Hematology and Oncology, the Department of Pediatrics/Pediatric Oncology, University Hospital Münster, Germany.
Uwe Cassens, MD, Institute of Transfusion Medicine, Department of Transplantation Immunology, Domagkstr. 11, 48129 Münster, Germany; e-mail: [email protected].Search for more papers by this authorIngo Mathias Barth
From the Institute of Transfusion Medicine, the Department of Medical Informatics and Biomathematics, the Department of Medicine/Hematology and Oncology, the Department of Pediatrics/Pediatric Oncology, University Hospital Münster, Germany.
Search for more papers by this authorClaudia Baumann
From the Institute of Transfusion Medicine, the Department of Medical Informatics and Biomathematics, the Department of Medicine/Hematology and Oncology, the Department of Pediatrics/Pediatric Oncology, University Hospital Münster, Germany.
Search for more papers by this authorRudolf-Josef Fischer
From the Institute of Transfusion Medicine, the Department of Medical Informatics and Biomathematics, the Department of Medicine/Hematology and Oncology, the Department of Pediatrics/Pediatric Oncology, University Hospital Münster, Germany.
Search for more papers by this authorJoachim Kienast
From the Institute of Transfusion Medicine, the Department of Medical Informatics and Biomathematics, the Department of Medicine/Hematology and Oncology, the Department of Pediatrics/Pediatric Oncology, University Hospital Münster, Germany.
Search for more papers by this authorJosef Vormoor
From the Institute of Transfusion Medicine, the Department of Medical Informatics and Biomathematics, the Department of Medicine/Hematology and Oncology, the Department of Pediatrics/Pediatric Oncology, University Hospital Münster, Germany.
Search for more papers by this authorWalter Sibrowski
From the Institute of Transfusion Medicine, the Department of Medical Informatics and Biomathematics, the Department of Medicine/Hematology and Oncology, the Department of Pediatrics/Pediatric Oncology, University Hospital Münster, Germany.
Search for more papers by this authorCorresponding Author
Uwe Cassens
From the Institute of Transfusion Medicine, the Department of Medical Informatics and Biomathematics, the Department of Medicine/Hematology and Oncology, the Department of Pediatrics/Pediatric Oncology, University Hospital Münster, Germany.
Uwe Cassens, MD, Institute of Transfusion Medicine, Department of Transplantation Immunology, Domagkstr. 11, 48129 Münster, Germany; e-mail: [email protected].Search for more papers by this authorIngo Mathias Barth
From the Institute of Transfusion Medicine, the Department of Medical Informatics and Biomathematics, the Department of Medicine/Hematology and Oncology, the Department of Pediatrics/Pediatric Oncology, University Hospital Münster, Germany.
Search for more papers by this authorClaudia Baumann
From the Institute of Transfusion Medicine, the Department of Medical Informatics and Biomathematics, the Department of Medicine/Hematology and Oncology, the Department of Pediatrics/Pediatric Oncology, University Hospital Münster, Germany.
Search for more papers by this authorRudolf-Josef Fischer
From the Institute of Transfusion Medicine, the Department of Medical Informatics and Biomathematics, the Department of Medicine/Hematology and Oncology, the Department of Pediatrics/Pediatric Oncology, University Hospital Münster, Germany.
Search for more papers by this authorJoachim Kienast
From the Institute of Transfusion Medicine, the Department of Medical Informatics and Biomathematics, the Department of Medicine/Hematology and Oncology, the Department of Pediatrics/Pediatric Oncology, University Hospital Münster, Germany.
Search for more papers by this authorJosef Vormoor
From the Institute of Transfusion Medicine, the Department of Medical Informatics and Biomathematics, the Department of Medicine/Hematology and Oncology, the Department of Pediatrics/Pediatric Oncology, University Hospital Münster, Germany.
Search for more papers by this authorWalter Sibrowski
From the Institute of Transfusion Medicine, the Department of Medical Informatics and Biomathematics, the Department of Medicine/Hematology and Oncology, the Department of Pediatrics/Pediatric Oncology, University Hospital Münster, Germany.
Search for more papers by this authorAbstract
BACKGROUND: Peripheral blood progenitor cell (PBPC) collections should be safe and efficient. Therefore, the influence and risk factors in large-volume leukaphereses (LVL) with standardized blood volumes was investigated.
STUDY DESIGN AND METHODS: In a total of 724 autologous LVL performed at our center, either 4× or 6× the patient's blood volume (PBV) was processed. The group with processing 4× the PBV showed a median of 31 circulating CD34+ cells per µL, and the group with processing 6× the PBV had a median of 13 CD34+ cells per µL before LVL. Individual clinical factors, laboratory factors, and apheresis run variables influencing the yields of PBPCs were retrospectively analyzed. Furthermore, the changes of laboratory variables and adverse effects during LVL were investigated.
RESULTS: Multivariate analysis identified “age,”“circulating CD34+ cells,” and “percentage of mononuclear cells” as only factors influencing the yields of PBPCs. Altogether, processing 6× versus 4× the PBV did not result in significantly higher yields of CD34+ cells for the total group, but requested PBPC yields were achieved more often after processing 6× the PBV in patients below 20 CD34+ cells per µL blood. Processing 6× versus 4× the PBV showed a significant difference for the decrease of platelets, but not for any other laboratory variable. Adverse effects were recorded in 4.97 percent of LVL without accumulation in one group.
CONCLUSION: In particular, patients with low amounts of circulating CD34+ cells profited from enlarged LVL demonstrating higher PBPC yields but comparable rates of adverse effects.
REFERENCES
- 1 Comenzo RL, Malachowski ME, Miller KB, et al. Engraftment with peripheral blood stem cells collected by large-volume leukapheresis for patients with lymphoma. Transfusion 1992; 32: 729-31.
- 2 Malachowski ME, Comenzo RL, Hillyer CD, et al. Large-volume leukapheresis for peripheral blood stem cell collection in patients with hematologic malignancies. Transfusion 1992; 32: 732-5.
- 3 Hillyer CD, Tiegerman KO, Berkman EM. Increase in circulating colony-forming units-granulocyte-macrophage during large-volume leukapheresis: evaluation of a new cell separator. Transfusion 1991; 31: 327-32.
- 4 Hillyer CD, Lackey DA 3rd, Hart KK, et al. CD34+ progenitors and colony-forming units-granulocyte macrophage are recruited during large-volume leukapheresis and concentrated by counterflow centrifugal elutriation. Transfusion 1993; 33: 316-21.
- 5 Cassens U, Sibrowski W. Large-volume leukapheresis in pediatric patients. Transfusion 1997; 37: 671-2.
- 6 Passos-Coelho JL, Braine HG, Wright SK, et al. Large-volume leukapheresis using regional citrate anticoagulation to collect peripheral blood progenitor cells. J Hematother 1995; 4: 11-9.
- 7 Gorlin JB, Vamvakas EC, Cooke E, et al. Large-volume leukapheresis in pediatric patients: processing more blood diminishes the apparent magnitude of intra-apheresis recruitment. Transfusion 1996; 36: 879-85.
- 8 Murea S, Goldschmidt H, Hahn U, et al. Successful collection and transplantation of peripheral blood stem cells in cancer patients using large-volume leukaphereses. J Clin Apheresis 1996; 11: 185-94.
- 9 Cull G, Ivey J, Chase P, et al. Collection and recruitment of CD34+ cells during large-volume leukapheresis. J Hematother 1997; 6: 309-14.
- 10 Yamaguchi E, Yamato K, Miyata Y. Kinetics of peripheral blood stem cell collection in large-volume leukapheresis for pediatric patients undergoing chemotherapy and adult patients before chemotherapy. J Hematother Stem Cell Res 2000; 9: 565-72.
- 11 Cassens U, Momkvist PH, Zuehlsdorf M, et al. Kinetics of standardized large volume leukapheresis (LVL) in patients do not show a recruitment phenomenon of peripheral blood progenitor cells (PBPC). Bone Marrow Transplant 2001; 28: 13-20.
- 12 Cassens U, Ostkamp-Ostermann P, Van Der Werf N, et al. Volume-dependent collection of peripheral blood progenitor cells during large-volume leukapheresis for patients with solid tumours and haematological malignancies. Transfus Med 1999; 9: 311-20.
- 13 Demirer T, Dagli M, Ilhan O, et al. A randomized trial of assessment of efficacy of leukapheresis volumes, 8 liters vs 12 liters. Bone Marrow Transplant 2002; 29: 893-7.
- 14 Ford CD, Greenwood J, Strupp A, Lehman CM. Change in CD34+ cell concentration during peripheral blood progenitor cell collection: effects on collection efficiency and efficacy. Transfusion 2002; 42: 904-11.
- 15 Smolowicz AG, Villman K, Berlin G, Tidefelt U. Kinetics of peripheral blood stem cell harvests during a single apheresis. Transfusion 1999; 39: 403-9.
- 16 Sevilla J, Gonzalez-Vicent M, Madero L, et al. Large volume leukapheresis in small children: safety profile and variables affecting peripheral blood progenitor cell collection. Bone Marrow Transplant 2003; 31: 263-7.
- 17 Cull G, Cannell P. Recruitment of CD34+ cells during large-volume leukapheresis. Transfusion 1997;37: 672-3.
- 18 Fischer J, Unkrig C, Ackermann M, et al. Intra-day CD34+ cell counts depend on time to plasma level after steady-state mobilization of PBPC by filgrastim (abstract). Blood 1994; 84(Suppl 1): 81.
- 19 Guidelines for the transplantation of peripheral blood stem cells. Wissenschaftlicher Beirat der Bundesärztekammer unter Mitwirkung des Paul-Ehrlich-Institutes. Deutsches Ärzteblatt 1997; 94: 1268-76.
- 20 Gutensohn K, Serke S, Cassens U, et al. Flow cytometry analysis of CD34 expressing hematopoietic cells in blood and cytapheresis products (in German). Infusionsther Transfusions Med 1996; 23: Suppl 2: 1-23.
- 21 Cassens U, Ostkamp-Ostermann P, Garritsen H, et al. Efficacy and kinetics of bone marrow processing and enrichment of haematopoietic progenitor cells (HPC) by a large-volume apheresis procedure. Bone Marrow Transplant 1997; 19: 835-40.
- 22 De Fabritiis P, Gonzalez M, Meloni G, et al. Monitoring of CD34+ cells during leukapheresis allows a single, successful collection of hemopoietic progenitors in patients with low numbers of circulating stem cells. Bone Marrow Transplant 1999; 23: 1229-36.
- 23 Moncada V, Bolan C, Yau YY, Leitman SF. Analysis of PBPC cell yields during large-volume leukapheresis of subjects with a poor mobilization response to filgrastim. Transfusion 2003; 43: 495-501.
- 24 Anderlini P, Przepiorka D, Seong C, et al. Factors affecting mobilization of CD34+ cells in normal donors treated with filgrastim. Transfusion 1997; 37: 507-12.
- 25 De La Rubia J, Arbona C, De Arriba F, et al. Analysis of factors associated with low peripheral blood progenitor cell collection in normal donors. Transfusion 2002; 42: 4-9.
- 26 De La Rubia J, Diaz MA, Verdeguer A, et al. Donor age-related differences in PBPC mobilization with rHuG-CSF. Transfusion 2001; 41: 201-5.
- 27 Sarkodee-Adoo C, Taran I, Guo C, et al. Influence of pre-apheresis clinical factors on the efficiency of CD34+ cell collection by large-volume apheresis. Bone Marrow Transplant 2003; 31: 851-5.
- 28 Miflin G, Charley C, Stainer C, et al. Stem cell mobilization in normal donors for allogeneic transplantation: analysis of safety and factors affecting efficacy. Br J Haematol 1996; 95: 345-8.
- 29 Yu J, Leisenring W, Bensinger WI, et al. The predictive value of white cell or CD34+ cell count in the peripheral blood for timing apheresis and maximizing yield. Transfusion 1999; 39: 442-50.
- 30 Moller AK, Dickmeiss E, Geisler CH, Christensen LD. Recruitment of CD34+ cells during large-volume leukapheresis. J Hematother Stem Cell Res 2001; 10: 837-53.
- 31 Torrabadella M, Olive T, Ortega JJ, Massuet L. Enhanced HPC recruitment in children using LVL and a new automated apheresis system. Transfusion 2000; 40: 404-10.
- 32 Reik RA, Noto TA, Fernandez HF. Safety of large-volume leukapheresis for collection of peripheral blood progenitor cells. J Clin Apheresis 1997; 12: 10-3.
- 33 Anderlini P, Przepiorka D, Seong D, et al. Clinical toxicity and laboratory effects of granulocyte-colony-stimulating factor (filgrastim) mobilization and blood stem cell apheresis from normal donors, and analysis of charges for the procedures. Transfusion 1996; 36: 590-5.
- 34
Kanold J,
Halle P,
Berger M, et al.
Large-volume leukapheresis procedure for peripheral blood progenitor cell collection in children weighing 15 kg or less: efficacy and safety evaluation.
Med Pediatr Oncol
1999; 32: 7-10.
10.1002/(SICI)1096-911X(199901)32:1<7::AID-MPO3>3.0.CO;2-Z CAS PubMed Web of Science® Google Scholar
- 35 LeBlanc R, Roy J, Demers C, et al. A prospective study of G-CSF effects on hemostasis in allogeneic blood stem cell donors. Bone Marrow Transplant 1999; 23: 991-6.
- 36 Goldberg SL, Mangan KF, Klumpp TR, et al. Complications of peripheral blood stem cell collections (abstract). Blood 1993; 82: 631a.
Citing Literature
